Human pathogenic microorganisms have developed a variety of strategies to i
nfect the host organism successfully, whereas the host has evolved a series
of defense mechanisms. In most cases, the epithelial cell layer represents
the first barrier for the bacterial pathogen and triggers the innate and i
nflammatory responses in the host. Epithelial cells release proinflammatory
mediators including cytokines and chemokines, leading to the subsequent at
traction of monocytes/macrophages. Therefore, epithelial cells represent an
immediate-early warning system in the host organism. Subsequent to the col
onization of the epithelial layer, invasive microbial pathogens often induc
e an acute inflammatory response, which functions to activate residential m
acrophages and recruits blood leukocytes to the site of infection. Distinct
receptors of the Toll family on the cell surface of immune cells mediate a
ntibacterial responses in mammals as well as in Drosophila. One of the most
important cellular factors involved in the regulation of the host innate a
ntimicrobial response is the immediate-early response transcription factor
nuclear factor (NF)-kappa B. Microbial pathogens activate cellular signal t
ransduction pathways that induce NF-kappa B activation, but pathogens also
find ways to overcome the innate immune response through active manipulatio
n of the NF-kappa B signal transduction pathways. Exploration of the mechan
isms that influence NF-kappa B activity could contribute to a better unders
tanding of the molecular pathogenesis of microbial infections and could be
important for potential therapeutic intervention that may be relevant in a
wide variety of inflammatory diseases. BIOCHEM PHARMACOL 60;8:1109-1114, 20
00. (C) 2000 Elsevier Science Inc.